HomeCompareNEE vs SYK

NEE vs SYK: Dividend Comparison 2026

NEE yields 2.52% · SYK yields 1.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEE wins by $661.7K in total portfolio value· pulled ahead in Year 4
10 years
NEE
NextEra Energy Inc.
● Live price
2.52%
Share price
$92.05
Annual div
$2.32
5Y div CAGR
60%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$705.0K
Annual income
$488,355.13
Full NEE calculator →
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →

Portfolio growth — NEE vs SYK

📍 NEE pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEESYK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEE + SYK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEE pays
SYK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEE
Annual income on $10K today (after 15% tax)
$214.48/yr
After 10yr DRIP, annual income (after tax)
$415,101.86/yr
SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
At 15% tax rate, NEE beats the other by $408,061.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEE + SYK for your $10,000?

NEE: 50%SYK: 50%
100% SYK50/50100% NEE
Portfolio after 10yr
$374.2K
Annual income
$248,319.05/yr
Blended yield
66.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

NEE
Analyst Ratings
23
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$93.27
+1.3% upside vs current
Range: $84.00 — $106.00
Altman Z
1.2
Piotroski
7/9
SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEE buys
8
SYK buys
0
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$NEE▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$NEE▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$NEE▲ Buy$1,001 - $15,0002025-11-05
Thomas Suozzi🏢 House$NEE▼ Sell$1,001 - $15,0002025-10-14
Julie Johnson🏢 House$NEE▼ Sell$1,001 - $15,0002025-08-14
Ritchie Torres🏢 House$NEE▼ Sell$1,001 - $15,0002025-07-11
Gilbert Cisneros🏢 House$NEE▼ Sell$1,001 - $15,0002025-06-25
Marjorie Taylor Greene🏢 House$NEE▲ Buy$1,001 - $15,0002025-06-06
Marjorie Taylor Greene🏢 House$NEE▲ Buy$1,001 - $15,0002025-05-05
Jefferson Shreve🏢 House$NEE▲ Buy$15,001 - $50,0002025-04-17
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEESYK
Forward yield2.52%1.04%
Annual dividend / share$2.32$3.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60%46.2%
Portfolio after 10y$705.0K$43.3K
Annual income after 10y$488,355.13$8,282.98
Total dividends collected$685.6K$21.0K
Payment frequencyquarterlyquarterly
SectorUtilitiesHealthcare
Analyst consensusBuyBuy
Analyst price target$93.27$428.67

Year-by-year: NEE vs SYK ($10,000, DRIP)

YearNEE PortfolioNEE Income/yrSYK PortfolioSYK Income/yrGap
1$10,614$403.73$10,852$152.43$238.00SYK
2$11,508$671.51$11,838$226.03$330.00SYK
3$12,891$1,140.99$13,004$336.89$113.00SYK
4← crossover$15,164$2,002.86$14,420$505.63+$744.00NEE
5$19,175$3,692.24$16,195$766.09+$3.0KNEE
6$26,894$7,316.39$18,504$1,175.64+$8.4KNEE
7$43,540$16,080.97$21,635$1,835.40+$21.9KNEE
8$85,252$40,797.74$26,082$2,932.10+$59.2KNEE
9$212,226$125,183.62$32,737$4,829.68+$179.5KNEE
10$705,038$488,355.13$43,312$8,282.98+$661.7KNEE

NEE vs SYK: Complete Analysis 2026

NEEUtilities

NextEra Energy, Inc., through its subsidiaries, generates, transmits, distributes, and sells electric power to retail and wholesale customers in North America. The company generates electricity through wind, solar, nuclear, coal, and natural gas facilities. It also develops, constructs, and operates long-term contracted assets that consists of clean energy solutions, such as renewable generation facilities, battery storage projects, and electric transmission facilities; sells energy commodities; and owns, develops, constructs, manages and operates electric generation facilities in wholesale energy markets. As of December 31, 2021, the company had approximately 28,564 megawatts of net generating capacity; approximately 77,000 circuit miles of transmission and distribution lines; and 696 substations. It serves approximately 11 million people through approximately 5.7 million customer accounts in the east and lower west coasts of Florida. The company was formerly known as FPL Group, Inc. and changed its name to NextEra Energy, Inc. in 2010. The company was founded in 1925 and is headquartered in Juno Beach, Florida.

Full NEE Calculator →

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →
📬

Get this NEE vs SYK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEE vs DUKNEE vs SONEE vs DNEE vs AEPNEE vs EXCNEE vs SCHDNEE vs JEPINEE vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.